Safety and efficacy of plasma exchange in pediatric transverse myelitis
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 9, 2017
- Accepted April 2, 2018
- First Published June 18, 2018.
Article Versions
- Previous version (June 18, 2018 - 12:49).
- You are viewing the most recent version of this article.
Author Disclosures
- Daniel K. Noland, MD and
- Benjamin M. Greenberg, MD, MHS
- Daniel K. Noland, MD and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
50% of my time is spent doing clinical apheresis, the treatment on which this study focuses. However, practice at this institution will not change as the conclusions are already followed.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Benjamin M. Greenberg, MD, MHS
NONE
NONE
Transverse Myelitis Association, funding for travel
NONE
Dr. Greenberg has filed patents on the use of antibody suppression in multiple sclerosis
NONE
NONE
Novartis, Alexion, EMD Serono
NONE
NONE
NONE
Medimmune, Chugai, Medday, Genentech
NIH RO1 NS071463, Co-investigator 2012-14
Unviersity of Texas Southwestern
Guthy Jackson Foundation, PCORI, Transverse Myelitis Association, National MS Society
NONE
NONE
NONE
NONE
NONE
NONE
- Departments of Pathology (DKN), Neurology and Neurotherapeutics (BMG), and Pediatrics (BMG), The University of Texas Southwestern Medical Center, Dallas; and Children's Health Dallas (DKN, BMG), TX.
- Correspondence
Dr. Greenberg Benjamin.Greenberg{at}utsouthwestern.edu or Dr. Noland Daniel.Noland{at}childrens.com
Article usage
Cited By...
The Nerve!: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Prognostic indicators of improvement with therapeutic plasma exchange in pediatric demyelinationAndrea Savransky, Adrian Rubstein, Marina Huaman Rios et al.Neurology, October 23, 2019 -
What's Happening
What's happening in Neurology® Clinical Practiceet al.Neurology, April 08, 2019 -
Article
Apheresis therapies for NMOSD attacksA retrospective study of 207 therapeutic interventionsIngo Kleiter, Anna Gahlen, Nadja Borisow et al.Neurology: Neuroimmunology & Neuroinflammation, September 26, 2018 -
Editorial
Therapeutic plasma exchange in children with acute demyelinationKids are not small adults!E. Ann Yeh, Kevin Rostásy et al.Neurology, October 23, 2019